Edward J. OLHAVA

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
NLRP3 modulators
- Patent number 11,827,632
- Issue date Nov 28, 2023
- Innate Tumor Immunity, Inc.
- Gary D. Glick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of synthesizing substituted purine compounds
- Patent number 11,753,433
- Issue date Sep 12, 2023
- Epizyme, Inc.
- Edward James Olhava
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Method of treating leukemia
- Patent number 11,633,420
- Issue date Apr 25, 2023
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of synthesizing substituted purine compounds
- Patent number 11,572,383
- Issue date Feb 7, 2023
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for treating conditions associated with...
- Patent number 11,505,571
- Issue date Nov 22, 2022
- Innate Tumor Immunity, Inc.
- Gary Glick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NLRP3 modulators
- Patent number 11,072,612
- Issue date Jul 27, 2021
- Innate Tumor Immunity, Inc.
- Gary D. Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of synthesizing substituted purine compounds
- Patent number 10,968,247
- Issue date Apr 6, 2021
- Epizyme, Inc.
- Edward James Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for treating conditions associated with...
- Patent number 10,961,270
- Issue date Mar 30, 2021
- Innate Tumor Immunity, Inc.
- Gary Glick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating leukemia
- Patent number 10,881,680
- Issue date Jan 5, 2021
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclic dinucleotides for treating conditions associated with STING...
- Patent number 10,723,756
- Issue date Jul 28, 2020
- Innate Tumor Immunity Inc.
- Gary Glick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclic dinucleotides for treating conditions associated with sting...
- Patent number 10,604,542
- Issue date Mar 31, 2020
- Innate Tumor Immunity, Inc.
- Gary Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NLRP3 modulators
- Patent number 10,556,903
- Issue date Feb 11, 2020
- Innate Tumor Immunity, Inc.
- Gary D. Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NLRP3 modulators
- Patent number 10,533,005
- Issue date Jan 14, 2020
- Innate Tumor Immunity, Inc.
- Gary Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 6,5-fused bicyclic heteroaryl compounds
- Patent number 10,273,223
- Issue date Apr 30, 2019
- Epizyme, Inc.
- Kevin Wayne Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of protein methyltransferase DOT1L and methods of use th...
- Patent number 10,112,968
- Issue date Oct 30, 2018
- Epizyme, Inc.
- Edward J. Olhava
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Methods of synthesizing substituted purine compounds
- Patent number 9,738,679
- Issue date Aug 22, 2017
- Epizyme, Inc.
- Edward James Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
- Patent number 9,718,788
- Issue date Aug 1, 2017
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of synthesizing substituted purine compounds
- Patent number 9,701,707
- Issue date Jul 11, 2017
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 6,5-fused bicyclic heteroaryl compounds
- Patent number 9,637,472
- Issue date May 2, 2017
- Epizyme, Inc.
- Kevin Wayne Kuntz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating leukemia
- Patent number 9,597,348
- Issue date Mar 21, 2017
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
- Patent number 9,458,108
- Issue date Oct 4, 2016
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carbocycle-substituted purine and 7-deazapurine compounds
- Patent number 9,394,310
- Issue date Jul 19, 2016
- Epizyme, Inc.
- Edward J. Olhava
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 6,5-fused bicyclic heteroaryl compounds
- Patent number 9,206,157
- Issue date Dec 8, 2015
- Epizyme, Inc.
- Kevin Wayne Kuntz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of synthesizing substituted purine compounds
- Patent number 9,175,032
- Issue date Nov 3, 2015
- Epizyme, Inc.
- Edward James Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
- Patent number 9,150,525
- Issue date Oct 6, 2015
- Millennium Pharmaceuticals, Inc.
- Christopher F. Claiborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
7-deazapurine modulators of histone methyltransferase, and methods...
- Patent number 9,145,438
- Issue date Sep 29, 2015
- Epizyme, Inc.
- Richard Chesworth
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted purine and 7-deazapurine compounds
- Patent number 9,096,634
- Issue date Aug 4, 2015
- Epizyme, Inc.
- Edward J. Olhava
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of histone methyltransferase, and methods of use thereof
- Patent number 9,029,343
- Issue date May 12, 2015
- Epizyme, Inc.
- Richard Chesworth
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 6,5-fused bicyclic heteroaryl compounds
- Patent number 8,962,620
- Issue date Feb 24, 2015
- Epizyme, Inc.
- Kevin Wayne Kuntz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
- Patent number 8,901,136
- Issue date Dec 2, 2014
- Millennium Pharmaceuticals, Inc.
- Stephen Critchley
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NLRP3 MODULATORS
- Publication number 20240067649
- Publication date Feb 29, 2024
- Innate Tumor Immunity, Inc.
- Gary D. Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS
- Publication number 20230287033
- Publication date Sep 14, 2023
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NLRP3 MODULATORS
- Publication number 20220289736
- Publication date Sep 15, 2022
- Innate Tumor Immunity, Inc.
- Gary D. Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEASOME INHIBITORS
- Publication number 20220017542
- Publication date Jan 20, 2022
- MILLENNIUM PHARMACEUTICALS,INC.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS
- Publication number 20210363171
- Publication date Nov 25, 2021
- Epizyme, Inc.
- Edward James Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INJECTABLE FORMULATIONS FOR TREATING CANCER
- Publication number 20210353661
- Publication date Nov 18, 2021
- Epizyme, Inc.
- Edward James OLHAVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING LEUKEMIA
- Publication number 20210268012
- Publication date Sep 2, 2021
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INJECTABLE FORMULATIONS FOR TREATING CANCER
- Publication number 20210251887
- Publication date Aug 19, 2021
- Epizyme, Inc.
- Edward James Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS
- Publication number 20210252035
- Publication date Aug 19, 2021
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS
- Publication number 20210230210
- Publication date Jul 29, 2021
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEASOME INHIBITORS
- Publication number 20210206784
- Publication date Jul 8, 2021
- Millennium Pharmaceuticals, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...
- Publication number 20210147467
- Publication date May 20, 2021
- Innate Tumor Immunity, Inc.
- Gary Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of E1 activating enzymes
- Publication number 20210070798
- Publication date Mar 11, 2021
- Millennium Pharmaceuticals, Inc.
- Stephen Critchley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEASOME INHIBITORS
- Publication number 20200407376
- Publication date Dec 31, 2020
- Millennium Pharmaceuticals, Inc,
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INJECTABLE FORMULATIONS FOR TREATING CANCER
- Publication number 20200397811
- Publication date Dec 24, 2020
- Epizyme, Inc.
- Edward James OLHAVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS
- Publication number 20200317643
- Publication date Oct 8, 2020
- Epizyme, Inc.
- Kevin W. KUNTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEASOME INHIBITORS
- Publication number 20200190118
- Publication date Jun 18, 2020
- Millennium Pharmaceuticals, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...
- Publication number 20200165288
- Publication date May 28, 2020
- Gary Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 MODULATORS
- Publication number 20200157097
- Publication date May 21, 2020
- Innate Tumor Immunity, Inc.
- Gary D. Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 MODULATORS
- Publication number 20200157096
- Publication date May 21, 2020
- Innate Tumor Immunity, Inc.
- Gary D. Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INJECTABLE FORMULATIONS FOR TREATING CANCER
- Publication number 20190388335
- Publication date Dec 26, 2019
- Epizyme, Inc.
- Edward James Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEASOME INHIBITORS
- Publication number 20190359636
- Publication date Nov 28, 2019
- Millennium Pharmaceuticals, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INJECTABLE FORMULATIONS FOR TREATING CANCER
- Publication number 20190350959
- Publication date Nov 21, 2019
- Epizyme, Inc.
- Edward James OLHAVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIC DINUCLEOTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH...
- Publication number 20190345191
- Publication date Nov 14, 2019
- Innate Tumor Immunity, Inc.
- Gary D. Glick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS
- Publication number 20190300502
- Publication date Oct 3, 2019
- Epizyme, Inc.
- Kevin W. KUNTZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS
- Publication number 20190300561
- Publication date Oct 3, 2019
- Epizyme, Inc.
- Edward J. OLHAVA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS
- Publication number 20190300562
- Publication date Oct 3, 2019
- Epizyme, Inc.
- Edward James OLHAVA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of E1 Activating Enzymes
- Publication number 20190255052
- Publication date Aug 22, 2019
- Millennium Pharmaceuticals, Inc.
- Steven P. LANGSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING LEUKEMIA
- Publication number 20190216838
- Publication date Jul 18, 2019
- Epizyme, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEASOME INHIBITORS
- Publication number 20190144470
- Publication date May 16, 2019
- Millennium Pharmaceuticals, Inc.
- Edward J. Olhava
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Edward J. OLHAVA

Person

Patents Grantslast 30 patents

NLRP3 modulators

Methods of synthesizing substituted purine compounds

Method of treating leukemia

Methods of synthesizing substituted purine compounds

Compounds and compositions for treating conditions associated with...

NLRP3 modulators

Methods of synthesizing substituted purine compounds

Compounds and compositions for treating conditions associated with...

Method of treating leukemia

Cyclic dinucleotides for treating conditions associated with STING...

Cyclic dinucleotides for treating conditions associated with sting...

NLRP3 modulators

NLRP3 modulators

Substituted 6,5-fused bicyclic heteroaryl compounds

Inhibitors of protein methyltransferase DOT1L and methods of use th...

Methods of synthesizing substituted purine compounds

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Methods of synthesizing substituted purine compounds

Substituted 6,5-fused bicyclic heteroaryl compounds

Method of treating leukemia

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Carbocycle-substituted purine and 7-deazapurine compounds

Substituted 6,5-fused bicyclic heteroaryl compounds

Methods of synthesizing substituted purine compounds

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

7-deazapurine modulators of histone methyltransferase, and methods...

Substituted purine and 7-deazapurine compounds

Modulators of histone methyltransferase, and methods of use thereof

Substituted 6,5-fused bicyclic heteroaryl compounds

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Patents Applicationslast 30 patents

NLRP3 MODULATORS

METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS

NLRP3 MODULATORS

PROTEASOME INHIBITORS

METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS

INJECTABLE FORMULATIONS FOR TREATING CANCER

METHOD OF TREATING LEUKEMIA

INJECTABLE FORMULATIONS FOR TREATING CANCER

SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS

METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS

PROTEASOME INHIBITORS

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...

Inhibitors of E1 activating enzymes

PROTEASOME INHIBITORS

INJECTABLE FORMULATIONS FOR TREATING CANCER

SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS

PROTEASOME INHIBITORS

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...

NLRP3 MODULATORS

NLRP3 MODULATORS

INJECTABLE FORMULATIONS FOR TREATING CANCER

PROTEASOME INHIBITORS

INJECTABLE FORMULATIONS FOR TREATING CANCER

CYCLIC DINUCLEOTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH...

SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS

METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS

METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS

Inhibitors of E1 Activating Enzymes

METHOD OF TREATING LEUKEMIA

PROTEASOME INHIBITORS